|
| Index | - | P/E | - | EPS (ttm) | -1.42 | Insider Own | - | Shs Outstand | 23.61M | Perf Week | -6.03% |
| Market Cap | 177.53M | Forward P/E | 2.84 | EPS next Y | 2.58 | Insider Trans | - | Shs Float | 23.61M | Perf Month | 43.16% |
| Income | -33.50M | PEG | - | EPS next Q | 0.65 | Inst Own | 4.10% | Short Float | 0.09% | Perf Quarter | 27.70% |
| Sales | 120.40M | P/S | 1.47 | EPS this Y | 153.40% | Inst Trans | -3.31% | Short Ratio | 0.13 | Perf Half Y | 59.69% |
| Book/sh | 2.97 | P/B | 2.47 | EPS next Y | 200.00% | ROA | -19.30% | Target Price | 7.99 | Perf Year | -9.73% |
| Cash/sh | 0.43 | P/C | 17.24 | EPS next 5Y | - | ROE | -44.50% | 52W Range | 3.81 - 10.66 | Perf YTD | 39.09% |
| Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | -3.60% | 52W High | -31.23% | Beta | - |
| Dividend % | - | Quick Ratio | 0.40 | Sales past 5Y | - | Gross Margin | 60.70% | 52W Low | 92.39% | ATR | 0.75 |
| Employees | 1550 | Current Ratio | 0.50 | Sales Q/Q | 18.20% | Oper. Margin | -29.60% | RSI (14) | 55.76 | Volatility | 11.85% 10.52% |
| Optionable | No | Debt/Eq | 1.34 | EPS Q/Q | -114.60% | Profit Margin | -27.80% | Rel Volume | 0.73 | Prev Close | 7.62 |
| Shortable | Yes | LT Debt/Eq | 0.89 | Earnings | Nov 30 BMO | Payout | - | Avg Volume | 172.31K | Price | 7.33 |
| Recom | 2.00 | SMA20 | 7.30% | SMA50 | 28.51% | SMA200 | 31.78% | Volume | 125,841 | Change | -3.81% |
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 25 treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite